Kevin Healy

Institution Name:

University of California, Berkeley

Total Awards:

3

Award Value:

$3,184,329

Share

Awards as PI

Program Type	Institution	Grant Title	Award Value
Quest - Discovery Stage Research Projects	University of California, Berkeley	Human Cardiac Chip for Assessment of Proarrhythmic Risk	$899,581
Progression Award - Discovery Stage Research Projects	University of California, Berkeley	Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy	$224,500
Quest - Discovery Stage Research Projects	University of California, Berkeley	Novel Lipid Nanoparticles for Enhancing eNOS Synthesis for Cardioprotection Post Myocardial Infarction	$2,060,248
			Total: $3,184,329.00

Publications

Sci Rep 2018 Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems. (PubMed: 30514966)
Front Pharmacol 2019 Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems. (PubMed: 32116671)
bioRxiv 2020 In Vitro Safety "Clinical Trial" of the Cardiac Liability of Hydroxychloroquine and Azithromycin as COVID19 Polytherapy. (PubMed: 33398282)
Clin Transl Sci 2021 In vitro safety "clinical trial" of the cardiac liability of drug polytherapy. (PubMed: 33786981)
Front Pharmacol 2021 Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics. (PubMed: 34421592)